COVID-19 Survey in Five National Longitudinal Cohort Studies: MRC National Survey of Health and Development, 2020-2021: Special Licence Access

DOI

Abstract copyright UK Data Service and data collection copyright owner.The Centre for Longitudinal Studies (CLS) and the MRC Unit for Lifelong Health and Ageing (LHA) have carried out two online surveys of the participants of five national longitudinal cohort studies which have collected insights into the lives of study participants including their physical and mental health and wellbeing, family and relationships, education, work, and finances during the coronavirus pandemic. The Wave 1 Survey was carried out at the height of lockdown restrictions in May 2020 and focussed mainly on how participants’ lives had changed from just before the outbreak of the pandemic in March 2020 until then. The Wave 2 survey was conducted in September/October 2020 and focussed on the period between the easing of restrictions in June through the summer into the autumn. A third wave of the survey was conducted in early 2021.In addition, CLS study members who had participated in any of the three COVID-19 Surveys were invited to provide a finger-prick blood sample to be analysed for COVID-19 antibodies. Those who agreed were sent a blood sample collection kit and were asked to post back the sample to a laboratory for analysis. The antibody test results and initial short survey responses are included in a single dataset, the COVID-19 Antibody Testing in the National Child Development Study, 1970 British Cohort Study, Next Steps and Millennium Cohort Study, 2021 (SN 8823).The CLS studies are:Millennium Cohort Study (born 2000-02) both cohort members and parents (MCS)Next Steps (born 1989-90) (NS)1970 British Cohort Study (BCS70)1958 National Child Development Study (NCDS).The LHA study is:MRC National Survey of Health and Development, 1946 British birth cohort (NSHD)The content of the MCS, NS, BCS70 and NCDS COVID-19 studies, including questions, topics and variables can be explored via the CLOSER Discovery website. 

The COVID-19 Survey in Five National Longitudinal Cohort Studies: MRC National Survey of Health and Development, 2020: Special Licence Access contains the data from Waves 1-3 for the 1946 birth cohort study. The Wave 1 Survey was programmed and administered by CLS/LHA using Qualtrics. The Wave 2 and Wave 3 Survey was programmed and administered by Kantar Public. Further information may be found on the CLS COVID-19 survey website. Latest edition information For the third edition (June 2021), the Wave 3 data have been added to the study, and the Wave 2 data file replaced with a new version. The documentation has also been updated.

Main Topics:

The study covers physical and mental health topics, wellbeing, family and relationships, education, work, and finances. For further information, see the user guide.

No sampling (total universe)

Self-administered questionnaire: Web-based (CAWI)

Identifier
DOI http://doi.org/10.5255/UKDA-SN-8732-3
Metadata Access https://datacatalogue.cessda.eu/oai-pmh/v0/oai?verb=GetRecord&metadataPrefix=oai_ddi25&identifier=422faa88aef7220e6296394570633ff247ceb219533188a9208f898204e498d0
Provenance
Creator University College London, MRC Unit for Lifelong Health and Ageing
Publisher UK Data Service
Publication Year 2020
Funding Reference Economic and Social Research Council; Medical Research Council
Rights Copyright&nbsp;MRC Unit for Lifelong Health and Ageing; <p style="margin: 0cm 0cm 6.75pt; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="font-size: 10pt; font-family: Helvetica, sans-serif;">The Data Collection is available to users registered with the UK Data Service.<o:p></o:p></span></p> <p style="margin: 0cm 0cm 6.75pt; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="font-size: 10pt; font-family: Helvetica, sans-serif;">Commercial use is not permitted.<o:p></o:p></span></p> <p style="margin: 0cm 0cm 6.75pt; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="font-size: 10pt; font-family: Helvetica, sans-serif;">Use of the data requires approval from the data owner or their nominee. Users must apply for access via a Special Licence application.<o:p></o:p></span></p> <span lang="EN-US" style="font-size: 10pt; line-height: 107%; font-family: Helvetica, sans-serif;">This data must not be accessed at a location outside European Economic Area or outside the following countries deemed by the European Commission to have an adequate level of data protection: Andorra, Argentina, Faroe Islands, Guernsey, Israel, Isle of Man, Japan, Jersey, New Zealand, Switzerland and Uruguay.</span>
OpenAccess true
Representation
Language English
Resource Type Numeric
Discipline Life Sciences; Medicine; Medicine and Health; Physiology
Spatial Coverage United Kingdom